Cite
HARVARD Citation
Eng, J. et al. (2016). Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. Journal for immunotherapy of cancer. 4 (1), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Eng, J. et al. (2016). Pancreatic cancer stem cells in patient pancreatic xenografts are sensitive to drozitumab, an agonistic antibody against DR5. Journal for immunotherapy of cancer. 4 (1), p. . [Online].